Shyra Gardai, chief scientific officer at the molecular glue start-up EpiBiologics, says Big Pharma’s recent interest in glue ...

On the heels of releasing its latest financial statement, Vancouver-based biotechnology company Absci announced it has met its first milestone in its collaboration with pharmaceutical giant AstraZenec ...

Analyst Silvan Tuerkcan of JMP Securities maintained a Buy rating on Terns Pharmaceuticals (TERN – Research Report), retaining the price ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

AbbVie’s deal flop and NFL high-profile draft busts have a lot in common.

including those discussed under the heading "Risk Factors" in Arcturus’ most recent Annual Report on Form 10-K, and in subsequent filings with, or submissions to, the SEC, which are available on the ...